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Objectives: This study was designed to examine the relationship between
ex vivo preservation time of the transplanted lung and the extent of
injury and to relate this to the severity of rejection with and without
allogenicity. Methods: Single lung transplantation was performed on two
groups of domestic swine. Group A (n 5 7) and group B (n 5 6) had ex
vivo preservation times of 4 and 15 hours, respectively, at 4° C hypo-
thermia. Group C (n 5 6) underwent 2 hours of warm ischemia via
dissection and isolation of the left lung with ligation of its bronchial
artery and crossclamping of the left pulmonary artery, vein, and
bronchus without explantation. Assessment measures included lung
function, antioxidant enzyme activities in the plasma and lung tissue,
levels of inflammatory mediators in the recipient plasma, and quanti-
fication of major histocompatibility complex II HLA-DR-b on host
peripheral lymphocytes. Results: All groups demonstrated increases in
interleukin-10, lung weight, and HLA-DR-b expression and decreases in
lung-tissue antioxidant enzyme activities, gas exchange, and lung com-
pliance. There was a strong positive correlation between ex vivo
preservation time and the expression of HLA-DR-b and a negative
correlation between ischemic time and lung-tissue superoxide dis-
mutase. Conclusions: These results suggest that the intensity of the host
immunogenic response is related to the severity of ischemia-reperfusion
injury and is independent of tissue incompatibility and/or the type of
ischemic insult. We conclude that the extension of ex vivo preservation
time may predispose the transplanted lung to more severe rejection.
(J Thorac Cardiovasc Surg 1998;115:978-89)
Ischemia-reperfusion injury (IRI) and graft rejec-tion are considered to be independent problems in
the management of solid organ transplantation.1, 2
Rejection of transplanted organs is thought to be
solely related to the problem of tissue incompatibil-
ity.3 Recently, however, a link between IRI and
organ rejection has been made.4 Other studies have
documented the importance of proinflammatory
cytokines, such as interleukin-2 (IL-2), tumor necro-
sis factor–a (TNF-a), and interferon-g,5, 6 and the
involvement of oxygen radicals7, 8 during IRI. Addi-
tionally, changes in the graft recovering from isch-
emic injury have been well characterized. There is
increased expression of major histocompatibility
complex class II (MHC II) on graft tissue9, 10; the
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cells infiltrating the graft are primarily polymorpho-
nuclear and lymphocytic in origin.11, 12 However, the
relationship between the severity of IRI (manifested
by alterations in inflammatory mediators, antioxi-
dant enzyme activities, and lung function) and host
response, as measured by the expression of MHC II
HLA-DR-b on host lymphocytes, has not been
previously evaluated. IRI induction of heightened
lymphocyte activation and recruitment in the recip-
ient may play an important role in the rejection
process. To clearly define IRI as an etiologic factor
in the rejection phenomenon, allogenicity must be
entirely excluded.
The specific aims of this protocol included the
following: (1) to evaluate the relationship between
ex vivo preservation time, extent of lung damage,
and the up-regulation of MHC II, (2) to determine
whether IRI is capable of the up-regulating of MHC
II independent of allogenicity, and (3) to examine
whether the type of ischemic insult (warm versus
cold) differently affects MHC II up-regulation. We
hypothesized that IRI induced by ex vivo preserva-
tion can up-regulate MHC II expression and prime
host peripheral lymphocytes for more severe rejec-
tion of transplanted organs and that this host immu-
nogenic response is independent of tissue incompat-
ibility and/or the type of ischemic insult.
Methods
Experimental protocol. Thirty-two domestic swine (Sus
serota domesticus) weighing 27 to 35 kg were divided into
three groups (A, B, and C). Single lung transplantation
was performed on group A (donor 5 7, recipient 5 7) and
group B (donor 5 6, recipient 5 6) with ex vivo preser-
vation times of 4 hours and 15 hours, respectively, at 4° C
hypothermia. Group C (n 5 6) underwent 2 hours of
warm ischemia by dissection and isolation of the left lung
with ligation of the bronchial artery and crossclamping of
the left pulmonary artery, vein, and bronchus. These
surgical procedures are routinely performed within our
laboratories and were preceded by sham operations on
animals that showed no changes in assessment measures
Fig. 1. Lung function parameters. Percent changes of PO2 (a), alveolar-arterial oxygen gradient (b),
alveolar-arterial oxygen ratio (c), and volume/pressure relationships (d) are shown. The solid line
represents group A (4 hours of cold ischemia); the dashed line represents group B (15 hours of cold
ischemia); and the dotted line represents group C (2 hours of warm ischemia). P values with an asterisk
indicate significant differences within groups, and those with a diamond sign indicate significant differences
between groups. pre, Before transplantation; 30m post, 30 minutes after reperfusion; 72h post, 72 hours
after reperfusion.
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(data not shown). Additionally, in this study each animal
served as its own control, when pre-IRI measures to
post-IRI measures were compared. This study was de-
signed to investigate the immunogenic response as a result
of IRI; therefore the use of immunosuppressive therapy
was not considered. All animals were maintained in
accordance with the guidelines of the Canadian Council of
Animal Care under the supervision of the Animal Care
Committee of the University of British Columbia.
Surgical technique. Anesthesia was induced with ket-
amine and maintained with isoflurane (0.5% to 2.0%).
After tracheal intubation, animals were ventilated to
normocapnia (Narkomed 2 Ventilator, N.A.D., Inc., Tel-
ford, Pa.) at a tidal volume of 500 ml and a rate of 12
breaths/min with an air/oxygen mixture (FiO2 5 0.5 to 1.0)
to maintain oxygen tension (PO2) greater than 70 mm Hg
throughout the experimental period for donors and recip-
ients. Heart rate, electrocardiogram, and urine output
were monitored continuously. Animals were instru-
mented, and simple left lung transplantations were per-
formed as described previously.13 Group C animals were
more sensitive to crossclamping; therefore the FiO2 was
kept at 1.0 throughout the experiment.
Group C animals were treated the same as the swine in
groups A and B until the harvesting of the lung. At this
point, the left lung was dissected free and isolated,
followed by ligation of the bronchial artery and cross-
clamping of the left pulmonary artery, vein, and bronchus.
During this period, the animal received injections of
pancuronium (2 mg/ml) and fentanyl (500 mg) to comple-
ment the isoflurane, which was decreased to a lower rate.
Warm ischemia was maintained for 2 hours, after which
the crossclamp was released and the isoflurane was re-
turned to the previous rate. Blood sample collection and
lung mechanics were performed at the same times in all
groups (before crossclamping and 30 minutes and 72
hours after reperfusion).
After lung implantation or reperfusion, the chest was
closed, at which time a chest tube was left for drainage; a
portable catheter (Port-A-Cath implantable access sys-
tem, SIMS Deltec, Inc., St. Paul, Minn.) was implanted in
the jugular vein. All animals received injections of bu-
prenorphine (300 mg/ml as analgesic) and calcilean
(20,000 IU/0.8 ml as anticoagulant) and the antibiotic
procaine penicillin G (300,000 IU/ml, Ethacilin, Rogar/
STB, London, Ontario, Canada; and 150,000 IU/ml; Pen-
long XL [procaine penicillin G and benzathine penicillin],
Rogar/STB). At 72 hours after reperfusion the animals
were reanesthetized. A median sternotomy was per-
formed for catheterization; the final postoperative func-
tional assessments were made, and biologic specimens
were harvested. The animals were killed at the end of the
experiment by sodium pentobarbital overdose.
Lung function. Hemodynamic and lung functional pa-
rameters were examined at three time intervals: before
transplantation, in the donor animal 1 hour before the
Fig. 2. Tissue antioxidant enzyme activities. Means 6 standard errors of SOD (a), catalase (b), GRed (c),
and GPx (d) are shown before transplantation (plain bars) and after transplantation (hatched bars). Group
A, 4 hours of cold ischemia); group B, 15 hours of cold ischemia; and group C, 2 hours of warm ischemia.
P values were derived from paired t tests at 95% confidence level of before and after measurements.
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harvesting (used as the baseline control), 30 minutes after
reperfusion, and 72 hours after reperfusion in the recipi-
ent animals. Hemodynamic parameters (systolic, diastolic,
and mean values for systemic arterial, pulmonary arterial,
right atrial, and pulmonary capillary wedge pressures)
were monitored continuously during transplantation and
72 hours after reperfusion. Assessment of pulmonary
function included serial measurements of PO2 and percent
oxygen saturation. The alveolar-arterial oxygen gradient
and alveolar-arterial oxygen ratio were calculated as pre-
viously described.13 Dynamic pulmonary compliance was
assessed with subdivisions of volume/pressure relation-
ships. Lung hemodynamics and compliances were then
assessed for both lungs; for the left lung by occlusion of
the right pulmonary artery and right bronchus.
Biochemistry
Antioxidant enzymes. The activities of antioxidant en-
zymes in the plasma and lung tissue were measured before
transplantation, 30 minutes after reperfusion, and at 72
hours after reperfusion. Before the left lung was harvested
from the donor animal, arterial blood samples and right
lung tissue were collected. Blood was collected in glass
tubes containing sodium heparin and centrifuged for 15
minutes at 1500 rpm and 4° C; the plasma was collected,
and red blood cells were washed twice with sterile cold
saline solution and stored at –80° C until analysis. Tissue
blocks from the upper lobe of the donor right lung
(assumed equal to left lung at baseline) were flash frozen
in liquid nitrogen and used to provide an estimate of
baseline tissue antioxidant activities. Blood samples (red
blood cells and plasma) were also collected from the
recipient animal. Blocks of tissue were collected from the
transplanted left lung. The activities of superoxide dis-
mutase (SOD), glutathione reductase (GRed), glutathi-
one peroxidase (GPx), and catalase (tissue only) were
quantitated by enzyme bioassay as described previous-
ly.14-17
Inflammatory mediators. Blood samples were collected
from the left atrium of the recipient animal before trans-
plantation, 30 minutes after reperfusion, and 72 hours
after reperfusion for the quantitation of IL-2, IL-4, IL-10,
TNF-a, and thromboxane (TxB2).
Blood samples for TxB2 assay were collected in sili-
conized glass tubes containing ethylenediaminetetraacetic
acid and indomethacin (INN: indometacin; 10 mg/ml).
Plasma was aliquoted with polypropylene pipette tips and
stored at –80° C until analysis. The plasma samples were
acidified to pH 3 with citric acid and applied to C2
minicolumns (Amprep, Amersham Life Science, Cleve-
land, Ohio) prewashed with methanol and water. Impuri-
ties were washed away with diethyl ether, and samples
were eluted with methyl formate and dried under a stream
of nitrogen. The purified TxB2 fraction was reconstituted
in assay buffer and quantitated by enzyme immunoassay
(Amersham Life Science) against a known standard con-
centration.
The IL and TNF-a blood samples were collected in
siliconized glass tubes containing sodium heparin. The
blood was centrifuged, and plasma aliquots were stored at
–80° C until quantitation. The levels of IL-2, IL-4, IL-10,
and TNF-a were determined by a competitive enzyme-
linked immunosorbent assay with labeled cytokine (Cyt
Immune Sciences Inc.). In brief, recipient plasma was
directly added to 96-well plates precoated with secondary
antibody and the anti-cytokine antibody, cytokine conju-
gate (labeled), strepavidin complex, substrate, and ampli-
fier were applied in successive steps. Color development
was monitored by optical density at 490 nm.
MHC expression
Host peripheral lymphocytes
CELL PREPARATION. Venous blood samples (21 ml)
were collected before transplantation and 24, 48, and 72
hours after reperfusion and fractionated with Hypaque-
Ficoll (Pharmacia) at 1500 rpm for 30 minutes. One
sample was kept separate and unficolled for complete
blood cell count. The buffy coat was removed and washed
once with phosphate-buffered saline solution and twice
with 2% culture media (TC199, Fisher Scientific Interna-
Table I. Lung functional parameters and plasma antioxidant enzyme activities
Group Time
Lung function parameters Plasma antioxidant enzymes
PO2
(mm Hg)
AaG
(mm Hg) AaR
Volume/
pressure
(ml/mm Hg)
SOD
(U/mg
protein)
GRed
(nmol/min/
mg protein)
GPx
(nmol/
min/mg
protein)
4 Hr of cold
ischemia
(n 5 7)
Before transplantation
30 Min. after transplantation
72 Hrs after transplantation
140 6 4.0 178 6 4.2 0.440 6 0.01 31.2 6 1.8 0.07 6 0.01 1.61 6 0.15 5.2 6 0.41
112 6 15 556 6 15* 0.167 6 0.02* 27.6 6 1.2 0.09 6 0.01 1.57 6 0.11 5.0 6 0.56
138 6 11 168 6 8.7 0.4501 6 0.03 29.1 6 1.7 0.05 6 0.01* 1.67 6 0.06 5.1 6 0.41
15 Hr of cold
ischemia
(n 5 6)
Before transplantation
30 Min. after transplantation
72 Hrs. after transplantation
159 6 10 160 6 12 0.499 6 0.03 31.1 6 3.5 0.13 6 0.01 2.0 6 0.16 5.4 6 0.41
116 6 17* 550 6 18* 0.174 6 0.03* 24.7 6 2.2 0.13 6 0.01 2.0 6 0.15 5.5 6 0.51
166 6 6.6 149 6 5.6 0.527 6 0.02 26.8 6 2.9 0.11 6 0.01 1.6 6 0.18 5.6 6 0.23
2 Hr of warm
ischemia
(n 5 6)
Before transplantation
30 Min. after transplantation
72 Hrs. after transplantation
464 6 43 189 6 25 0.601 6 0.08 30.6 6 1.6 0.10 6 0.02 1.0 6 0.06 3.8 6 0.26
419 6 87 332 6 45† 0.570 6 0.10† 26.1 6 1.5 0.09 6 0.01 1.1 6 0.06 4.2 6 0.27
323 6 74† 274 6 60 0.499 6 0.07 24.7 6 1.4* 0.08 6 0.01 0.92 6 0.07 4.0 6 0.15
All values are given as mean 6 standard error. AaG, Alveolar-arterial oxygen gradient; AaR, alveolar-arterial oxygen ratio.
*Significant difference within groups.
†Significant difference between groups.
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tional, Pittsburgh, Pa.) at 1500 rpm for 15 minutes. Isolated
cells were then counted and frozen in TC199 at 10%
dimethylsulphoxide and 20% fetal calf serum and stored at
–70° C until flow cytometry analysis (Epic Profile, Coulter
Corporation, Hialeah, Fla.).
FLOW CYTOMETRY. Two-color flow cytometry with
swine anti-HLA-DR-b (MSA3, 1:20 dilution) and anti-
CD3 (8E6, 1:20 dilution) primary antibodies (VMRD
Inc., Pullman, Wash.) was performed on isolated lympho-
cytes. Bitmapping of the lymphocyte population was per-
formed with swine anti-CD45 (Pan-Leuc, 1:40 dilution)
and anti-monocytic antibodies (1:20 dilution). Two sec-
ondary goat anti-mouse antibodies labeled with phyco-
erythrin (1:100 dilution) and fluorescein isothiocyanate
(1:40 dilution) were used for staining the lymphocytes
bound to primary antibodies. Cells were incubated with
primary antibodies at 4° C for 30 minutes and then stained
with secondary antibodies at 4° C for 30 minutes. After
each incubation, cells were washed with 2% TC199 for 15
minutes and centrifuged at 1500 rpm. Stained cells were
fixed with 1% formaldehyde and kept at 4° C before flow
cytometry analysis (Epic Profile).
Graft tissue. At the same sampling times as pathology
specimens, sections of the upper lobes of the donor right
lung before transplantation and the left transplanted lung
after harvesting from the recipient were taken, immersed
in optimal cutting temperature compound (Tissue-Tek,
Miles Inc., Division of Bayer Corp., Tarrytown, N.Y.), and
frozen in blocks by immersion in 2-methylbutane cooled
by liquid nitrogen and stored at –70° C. Immunohisto-
chemistry for MHC II expression was performed on 5 mm
thick cryostat sections fixed for 10 minutes in 4° C ace-
tone. The sections were rehydrated in TRIS buffer (0.05
mol/L, pH 7.6) for 4 minutes, and excess fluid was
removed by blotting. Non-immune serum (normal goat
serum 1:20 dilution, Cedar Lane Laboratories Limited,
Hornby, Ontario, Canada) was added for 10 minutes at
room temperature; when removed, the primary antibody
(mouse anti-swine MHC II HLA-DR, 1:1000 dilution;
VMRD Inc.) was applied for 60 minutes at room temper-
ature. The sections were then washed twice with TRIS
buffer for 5 minutes, and endogenous peroxide activity
was blocked by the application of TRIS-H2O2 solution 1:1
for 25 minutes at room temperature. After a 5-minute
wash with TRIS buffer, the secondary peroxidase conju-
gated antibody (goat anti-mouse IgG hematoxylin and
eosin, 1:200 dilution; Jackson Immune Research Labora-
tories Inc.) was applied for 80 minutes at room tempera-
ture. Washes with TRIS buffer for 5 minutes and acetate
buffer (0.1 mol/L, pH 5.2) for 3 minutes were performed,
and freshly prepared substrate (3-amino-9-ethyl carba-
zole; Sigma Chemical Co., St. Louis, Mo.) was added for
7 minutes. Finally, the sections were washed 1 minute
under tap water, counterstained with Carazzi’s hematox-
ylin, and crystal mounted. The MHC II staining was
graded on a semiquantitative scale of 1 to 41.
Pathologic analysis. The weight of the left lung was
measured after 4 or 15 hours of ex vivo preservation
Fig. 3. Plasma cytokine levels. Percent changes of IL-2 (a), IL-4 (b), IL-10 (c), and TNF-a (d) are shown.
The solid line represents group A; the dashed line represents group B; and the dotted line represents group
C. P values with an asterisk depict significant differences within groups, and those with a diamond sign
depict significant differences between groups. pre, Before transplantation; 30m post, 30 minutes after
reperfusion; 72h post, 72 hours after reperfusion.
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before implantation and at 72 hours after reperfusion,
immediately after the transplanted lung was harvested
from the recipient. In group C, the weight of the left lung
could only be measured at 72 hours after reperfusion.
From groups A and B, lung tissue was collected from
the discarded donor right lung at organ harvest and the
transplanted left lung for pathologic analysis. In group C,
lung tissue was collected both before and after cross-
clamping. The lung tissue was perfused with 10% neutral
buffered formalin and stored for 24 hours. Tissue blocks
were collected in a systematic fashion from the upper,
middle, and lower lobes and processed for light micros-
copy with hematoxyin and eosin staining.
Statistics. Analysis of variance with repeated measures
and standard errors were performed on the raw data of
lung functional parameters. For presentation purposes
only, the results are shown as percent change from
baseline with significance levels indicated by denoted
symbols. Similarly, the raw data of the plasma antioxidant
enzymes and plasma cytokines were analyzed by analysis
of variance with repeated measures and standard errors.
Tissue antioxidant enzymes and lung weights were ana-
lyzed by paired t tests (donor before transplantation
versus after transplantation). MHC II HLA-DR-b expres-
sion on host peripheral lymphocytes was analyzed by
nonparametric Mann-Whitney tests.
Results
Lung function. Lung functional parameters
(PO2 and alveolar-arterial oxygen gradient and
ratio) depicted in Fig. 1, a, b, and c demonstrated
a reduction in oxygen exchange for all three
Table II. Plasma cytokine levels
Group Time
Plasma cytokine levels
IL-2
(ng/ml)
IL-4
(ng/ml)
IL-10
(ng/ml)
TNFa
(ng/ml)
TxB2
(pg/ml)
4 Hr of cold
ischemia
(n 5 7)
Before transplantation
30 Min. after transplantation
72 Hrs. after transplantation
2.3 6 0.66 3.5 6 0.94 0.54 6 0.10 0.41 6 0.07 8.7 6 1.3
1.7 6 0.26 2.5 6 0.72 0.63 6 0.20 0.85 6 0.22 13.7 6 3.6
1.3 6 0.17 3.6 6 0.75 2.1 6 0.61*† 0.66 6 0.08 6.9 6 1.1
15 Hr of cold
ischemia
(n 5 6)
Before transplantation
30 Min. after transplantation
72 Hrs. after transplantation
0.77 6 0.14 1.4 6 0.27 0.35 6 0.05 0.48 6 0.22 17.9 6 5.5
0.6 6 0.14 1.3 6 0.19 0.28 6 0.09 0.19 6 0.06 22.1 6 6.5
1.1 6 0.16 2.1 6 0.44 0.54 6 0.09 0.38 6 0.06 21.3 6 4.7
2 Hr of warm
ischemia
(n 5 6)
Before transplantation
30 Min. after transplantation
72 Hrs. after transplantation
0.35 6 0.06 0.10 6 0.03 0.38 6 0.04 0.64 6 0.16 27.9 6 2.1
0.43 6 0.13 0.25 6 0.18 0.47 6 0.12 0.80 6 0.37 24.8 6 5.0
0.77 6 0.19 0.14 6 0.09 0.79 6 0.10* 0.62 6 0.10 26.8 6 4.0
All values are given as mean 6 standard error.
*Significant difference within groups.
†Significant difference between groups.
Table III. MHC II HLA-DR-b expression on CD31 host peripheral lymphocytes
Group Time
Host peripheral lymphocytes
MHC II
intensity
MHC1CD31
cells (no.)
4 Hr of cold
ischemia
(n 5 7)
Before transplantation
24 Hrs. after transplantation
48 Hrs. after transplantation
72 Hrs. after transplantation
5.694 6 0.674 2797 6 120
4.985 6 0.164 2367 6 90†
8.209 6 0.690* 2461 6 117*
6.845 6 0.479 2366 6 44*
15 Hr of cold
ischemia
(n 5 6)
Before transplantation
24 Hrs. after transplantation
48 Hrs. after transplantation
72 Hrs. after transplantation
5.337 6 0.369 706 6 19
7.582 6 0.504† 611 6 8*
13.702 6 1.514† 575 6 29*
8.205 6 0.930* 649 6 9
2 Hr of warm
ischemia
(n 5 6)
Before transplantation
24 Hrs. after transplantation
48 Hrs. after transplantation
72 Hrs. after transplantation
5.428 6 0.787 1698 6 197
7.450 6 0.589 1305 6 41†
19.163 6 0.955† 493 6 96†
10.106 6 1.754† 895 6 55
All values are given as mean 6 standard error.
*Significant difference within groups (p 5 0.03).
†Significant difference within groups (p 5 0.05).
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 5
Qayumi et al. 9 8 3
groups after 30 minutes of reperfusion, but this
was significant only in group B (p 5 0.02) for PO2.
At 72 hours after reperfusion, however, these gas
exchange parameters returned to their preisch-
emic levels for animals in groups A and B after 4
and 15 hours of hypothermic storage and allo-
transplantation, respectively. In contrast, for
group C, in which the animals were subjected to 2
hours of warm ischemia by simple crossclamping,
gas exchange deteriorated and at 72 hours after
reperfusion PO2 and alveolar-arterial oxygen gra-
dients and ratios were significantly decreased.
Lung compliance measured by the volume/pres-
sure relationship indicated similar changes at 30
minutes after reperfusion for all groups (Fig. 1, d).
The recovery of lung compliance, however, was
not complete at 72 hours for all groups and was
significantly (p 5 0.03) less for group C. Results of
the functional parameters are presented as per-
cent change in Fig. 1, and their real values 6
standard errors are presented in Table I.
Biochemistry. Fig. 2 shows the postischemic anti-
oxidant enzyme status of the lung tissue after 72 hours
after reperfusion compared with the pretransplanta-
tion donor right lung (control) of the same animal. A
significant (p 5 0.02) decrease in SOD in groups A
and B was observed, and this was positively correlated
with increased ex vivo preservation time (r2 5 0.76). In
group C, however, SOD did not show a significant
reduction. Tissue catalase (groups A and B) and GRed
(groups A and C) were also significantly depleted. The
activity of GPx was unchanged in all groups.
The activities of plasma antioxidant enzymes
(SOD, GRed, and GPx) were measured in the
recipient before transplantation and after 30 min-
utes after reperfusion and 72 hours after reperfusion
(Table I). Within group A, which underwent the
shortest storage time, SOD was the only plasma
antioxidant enzyme that was significantly decreased
(p 5 0.01) 72 hours after reperfusion.
The levels of cytokines IL-2, IL-4, IL-10, TNF-a,
and TxB2 were assayed in the plasma of the recipi-
Fig. 4. Expression of MHC II HLA-DR-b on CD31 host peripheral lymphocytes. a, MHC II HLA-DR-b
intensity per MHC1CD31 cell. b, The number of host peripheral lymphocytes (B and T cells). The solid
line rpresents group A; the dashed line represents group B, and the dotted line represents group C. P values
were derived by nonparametric Mann/Whitney tests. c, Regression analysis of MHC II intensity per cell
versus ischemic time. d, An example of a bitmap generated by flow cytometry analysis – quadrant 2 denotes
MHC1CD31 cells. pre, Before transplantation; 24h post, 24 hours after reperfusion; 48h post, 48 hours
after reperfusion; 72h post, 72 hours after reperfusion; PE, phycoerythrin; FITC, fluorescein isothiocyanate;
2h post, 2 hours after reperfusion.
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ent before transplantation and after 30 minutes
after reperfusion and 72 hours after reperfusion
(Fig. 3, a through d). IL-2, IL-4, and TNF-a levels
did not change significantly with respect to the
duration and/or type of ischemic damage. The level
of IL-10, however, was increased significantly in all
groups at 72 hours after reperfusion. TxB2 levels
were also increased in group A but had a tendency
to decrease in groups B and C. The levels of plasma
cytokines are presented as percent change in Fig. 3;
the absolute values 6 standard errors of both
plasma cytokines and TxB2 are given in Table II.
MHC II expression
Host peripheral lymphocytes. Table III presents
the fluorescence-activated cell sorter analysis as
total MHC II intensity and the number of MHC II1
CD31 counted in the periphery. These results
showed that MHC II HLA-DR-b expression on host
peripheral CD31 T lymphocytes had a tendency to
increase in the first 24 hours after reperfusion (Fig.
4, a). At 48 hours, the MHC II intensity per cell
reached its peak for all groups. At 72 hours after
reperfusion, the values had generally begun to de-
cline toward baseline levels. The peak levels of
MHC II expression on individual CD31 T lympho-
cytes were significantly (p 5 0.01) higher after 15
hours than after 4 hours of storage. Fig. 4, c, also
shows that if the relationship of cold ischemic time
to MHC II intensity per cell were linear, then the
rate of MHC II expression per hour would have
been 0.499 channel intensity per hour of ex vivo
preservation based on the illustrated correlation
(coefficient 5 0.88). The data from group C also
indicate that an ischemic insult itself without the
complication of tissue incompatibility is capable of
intensifying the expression of MHC II on peripheral
T lymphocytes. Two hours of warm ischemia af-
fected the expression of MHC II more severely than
allotransplantation after 4 or 15 hours of ex vivo
preservation. In addition, the number of lympho-
cytes (T and B) in the periphery shows a significant
(p 5 0.05) decrease for groups B and C in the first
48 hours after reperfusion (from complete blood
cell count, Fig. 4, b). Results were expressed as
mean fluorescence intensity of MHC1 CD31 cells
and the number of MHC1 CD31 cells (Table III).
Pathologic evidence. Lung weights increased sig-
nificantly (p , 0.0001) after transplantation in
groups A and B compared with pretransplantation
values; this was reflected histologically by expansion
of pleural and interlobular septal lymphatics with
edema fluid that often contained significant quanti-
ties of inflammatory cells. There was no gross evi-
dence of intimal thrombosis at either the site of
Fig. 5. Histologic comparison of lung tissue from allografts undergoing 4 hours (a) and 15 hours (b) cold
ischemic preservation time, and 2 hours of warm, in situ ischemia (c). a, Expansion of the interlobular
septal tissue by lymphatic dilation (L) and tissue edema (*). There is a sparse alveolar infiltrate (arrow).
b, Alveolar infiltrates are more dense (*) and are composed of mononuclear and polymorphonuclear
inflammatory cells. c, Foci of acute alveolar hemorrhage are seen (arrow), in addition to the inflammatory
infiltrate. (Hematoxylin and eosin; original magnification 3125, all panels.)
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 5
Qayumi et al. 9 8 5
arterial crossclamping or at the anastomotic suture
line. Intraalveolar infiltrates were identified in all
groups at the time of death and consisted of a
polymorphous mixture of neutrophils, alveolar mac-
rophages, lymphocytes, and plasma cells (Fig. 5).
Qualitative analysis identified a greater inflamma-
tory component in group B, which underwent the
longest ischemic time. The infiltrates in groups A
and C tended to be more patchy and less dense. In
all groups, there were focal areas of diffuse alveolar
damage that were accompanied by microvascular
thrombosis, which was presumed to be the result of
direct microvascular injury from IRI. Contralateral
(native) lungs also demonstrated edema and alveo-
lar infiltrates, although they were obviously reduced
relative to the operated lungs.
Immunohistochemical analysis confirmed a post-
operative up-regulation in the expression of MHC II
antigen in all groups (Figs. 6 and 7). Positive staining
was observed on endothelium (large vessels and
alveolar capillaries) and on inflammatory cells. In-
creased expression with the tissue sections was seen
in concert with the increase in inflammatory infil-
trates in each group and thus paralleled the findings
of the routine light microscopic sections. Increased
density of antigen, as measured semiquantitatively
on endothelial surfaces, was not believed to be differ-
ent among groups A, B, and C; however, this obser-
vation may reflect the small size of the tissue sample
and the patchy nature of the inflammatory process.
Discussion
For many years IRI has been suggested to be
one of the etiologic factors in the rejection of
transplanted organs.1, 2, 4 Initial clinical observa-
tions reported more persistent and more severe
rejection of organs that had extended ex vivo
preservation times in comparison to organs trans-
planted within expected preservation times.3
These observations triggered the interest of inves-
tigators to determine whether factors in addition
to tissue incompatibility are involved in organ
rejection. It was hypothesized that IRI itself might
play a role in the cause of organ rejection after
transplantation. Reperfusion of the transplanted
organ triggers a cascade of events, including the
generation of oxygen radicals, the inactivation of
antioxidant enzymes, and the release of inflamma-
tory mediators, ultimately leading to organ dam-
age and subsequent rejection.18 Most experimen-
tal work in this area has focused on the expression
of MHC class II on transplanted donor organs.9, 10
The present experimental protocol was designed
to investigate the up-regulation of MHC not only
Fig. 6. Immunohistochemistry of lungs undergoing 2 hours of warm in situ ischemia: a, preischemic
biopsy; b, lung at time of death. In a, basal, or constituitive expression of MHC II is identified on vascular
endothelium (arrow); there is no alveolar inflammatory infiltrate (*). In b, there is a large increase in MHC
II tissue expression contributed to by an influx of MHC II1 inflammatory cells and increased expression
of MHC II on capillary and larger vessel endothelium (arrow). (Hematoxylin and eosin; original
magnification 3125, both panels.)
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in the transplanted tissue but also in circulating
host T lymphocytes and to correlate this MHC II
up-regulation with functional, biochemical, and
morphologic impairment of ischemic-reperfused
organs with and without allotransplantation.
Comparison of groups A and B, which underwent 4
or 15 hours of cold ischemic storage, respectively,
demonstrated a clear relationship between ex vivo
preservation time, degree of tissue damage, and MHC
II up-regulation. Reduction of lung functional capac-
ity, as reflected in decreased oxygen exchange and
compliance used as a measure of IRI, has been
observed in our previous experiments19, 20 and in those
of others.21, 22 However, the present report further
suggests that with increased ex vivo preservation time
the loss of functional capacity becomes more severe.
This relationship between ex vivo preservation time
and functional impairment is confirmed by our histo-
logic analyses to be associated with intraalveolar and
interstitial edema formation, tissue hemorrhage, and
leukocyte infiltration. This loss of function and of
morphologic integrity of lung has been postulated to
be due to the damaging effect of oxygen-derived free
radicals produced during postischemic reperfu-
sion.23, 24 Because direct measurement of oxygen-de-
rived free radicals is extremely difficult in an in vivo
model such as ours, we measured the plasma and
tissue antioxidant enzymes that serve as the first lines
of defense against the oxygen-derived free radical–
induced damage.7 Significant inhibition of antioxidant
enzymes such as SOD (p , 0.05), catalase (p , 0.05),
and GRed (p 5 0.001) within transplanted lung tissue
suggested that the functional and morphologic impair-
ment observed might be due to the effect of oxygen-
derived free radicals and lipid peroxidation during
ischemia and reperfusion.18, 25 Alternatively, it could
be suggested that the observed antioxidant alterations
might be a consequence of IRI.
Results of the flow cytometry analyses of host
peripheral CD31 T lymphocytes in the allotrans-
plantation study demonstrated the up-regulation of
MHC II HLA-DR-b to correlate positively (coeffi-
cient 5 0.88) with the time of ex vivo preservation
and with functional, biochemical, and morphologic
changes. The MHC II up-regulation on peripheral T
lymphocytes also correlates with the transplanted
lung tissue MHC up-regulation as detected by im-
munohistochemistry. Although it has been shown by
other investigators that IRI increases MHC expres-
sion within the graft tissue,9, 10 to our knowledge,
this is the first documentation of a relationship of ex
vivo preservation time with MHC II up-regulation
on host peripheral CD31 lymphocytes and correla-
tion of this up-regulation to functional, pathologic,
and biochemical manifestations of IRI in trans-
planted lung.
Fig. 7. Immunohistochemistry of lungs undergoing 4 hours of cold, ex vivo preservation before implan-
tation. a, Tissue before transplantation shows low basal expression of MHC II antigen on vascular
endothelium (arrow). b, In tissue after transplantation, endothelial MHC II expression is increased (arrow).
(Hematoxylin and eosin; original magnification 3125, both panels.)
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To explain the effect of IRI alone without alloge-
nicity, we also created a model of ischemic injury by
dissection of the left lung, simple occlusion of the
left pulmonary artery, vein, and bronchus, and liga-
tion of the bronchial artery. It is well accepted that
cold storage is a preservation technique for reducing
the degree of ischemic damage; therefore a pilot
study with different ischemic time periods was per-
formed (data not shown) to allow the identification
of a warm ischemic time that closely produced injury
comparable to that induced by 4 to 15 hours of cold
storage. On the basis of the pilot study, 2 hours of
warm ischemia was chosen to examine the relation-
ship of IRI and host response in a system that
eliminated tissue incompatibility. In group C, the
biochemical, functional, and morphologic results
were very similar to the cold preservation measure-
ments; in some cases these were even enhanced. In
particular, the MHC up-regulation was greater than
100% from baseline, demonstrating that the IRI
may directly contribute to host immunogenic re-
sponse and subsequent organ rejection. It is also
interesting to note that the chosen durations of
warm and cold ischemic conditions produced very
similar functional and biochemical results. More-
over, the specific effect of IRI on the MHC up-
regulation with and without cold storage has not to
our knowledge been reported elsewhere.
Knowing that IRI can produce functional and
morphologic deterioration and that MHC II up-
regulation can lead to subsequent rejection, we tried
to identify the factors that may be responsible for
MHC II up-regulation in both ischemic models.
Other studies have demonstrated the link between
the production of IL-2, TNF-a, and interferon-g
and allogenic rejection caused by tissue incompati-
bility.6, 28 However, it is not known to what extent
these same cytokines are involved in IRI induction
of MHC II up-regulation as in antigenic up-regula-
tion. In our experimental protocol, the levels of IL-2
and TNF-a in the peripheral blood were examined
as the primary cytokines implicated in MHC II
up-regulation associated with tissue incompatibili-
ty.5, 26 In addition, the proliferation-associated cyto-
kine IL-4 and the immunoregulatory cytokine IL-10
were investigated to identify the role of other mol-
ecules in the process of MHC up-regulation, possi-
ble inhibitory feedback mechanisms, and rejection
caused by IRI. The results of this study demon-
strated that IL-2 and IL-10 were the two cytokines
that may have a direct effect on MHC II up-
regulation triggered by IRI. Although levels of IL-2
did not increase significantly, they did show a ten-
dency to increase as the severity of damage in-
creased. IL-10, on the other hand, demonstrated a
significant rise; but the degree was inversely propor-
tional to the extent of lung damage. TNF-a and IL-4
showed no significant changes, which would appear
to detract from their possible involvement in this
mechanism of MHC II up-regulation.
In summary, results of this study suggest that IRI
can up-regulate the MHC II HLA-DR-b in host
peripheral lymphocytes and in transplanted lung
tissue and that this is increased by lengthening the
ex vivo preservation time. Our findings also suggest
that this MHC II up-regulation is independent of
tissue incompatibility and is related to the degree of
damage caused by IRI. The mechanism by which
this phenomenon occurs has yet to be investigated;
however, one or more distinct regulatory cytokines
may be involved.
This study is relevant to the realm of clinical
transplantation. Although IRI cannot be considered
the most important factor in rejection of trans-
planted organs, it clearly can be a pivotal factor in
priming the recipient response and enhancing the
rejection of transplanted organs. Thus renewed ef-
fort has to be directed to improving preservation of
all donor organs.
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Discussion
Dr. Nasser K. Altorki (New York, N.Y.). Have you
measured the MHC expression before reperfusion?
Dr. Qayumi. Yes. We measured the MHC II expression
before reperfusion and then at 1 day, 2 days, and 3 days
after the reperfusion; the most expression was seen at 48
hours after the reperfusion.
Dr. Chi-Ming Wei (Baltimore, Md.). Do you have data to
show immunohistochemical staining for TNF-a and IL-10?
Dr. Qayumi. We did not look for the protein expression
in the lung tissue, but we looked at the level of cytokines
in plasma that we thought would be involved in the
mechanism of this expression. And, as you know, in
allogenicity, IL-2, TNF-a, and interferon-g are involved.
We thought we should look at some other regulatory
cytokines, such as IL-4 and IL-10 in particular; we found
that the involvement of cytokines like IL-2 or TNF-a were
not significant. But we found that IL-10 was significantly
different, and that difference is, as I said, inverse because
it is a regulatory cytokine.
Dr. William A. Cook (North Andover, Mass.). Could you
show the slide that had the microscopic sections on it
[Figs. 5 to 7]? What I was going to try to point out to you
is that in the left-hand side of the slide what you have is a
congested-looking interalveolar septum. What we were
not seeing, looking at this on microscopic flow, was these
clumps sticking to the endothelial cells. At that time, the
whole concept was that these changes happened because
the endothelium was somehow abnormal. What we actu-
ally did see was these increasingly large clumps of cells,
and we literally saw them bounce off from the endothe-
lium many times in many fields so that it did not appear to
be a stickiness in the endothelial cells. Instead, these
clumps would build up and keep packing into the smaller
vessels until enough of the flow through the lungs was
eradicated and just shut down completely. Then, of
course, you would get injury because the tissue oxygen-
ation was poor.
Your last slide was very provocative. We took some of
these clumps out and dissected them, and there appeared to
be some sort of a lymphocyte or plasmocyte or something in
the middle with sticky red cells all clumped around it.
Your last slides suggested to me that perhaps the effect
you are describing is, in fact, an intravascular cellular
response that leads to the sort of phenomenon we ob-
served looking at it microscopically.
Dr. Qayumi. I agree with you, it could be that intravascu-
lar phenomenon as well. But I would believe that it is the
mechanism of IRI with respect to the ischemic damage to
the endothelial cells and also to the adhesion of white blood
cells and lymphocytes and so on. So I believe it could be.
Dr. Cook. Is that the secondary effect? In other words,
if the vessel gets plugged up, then of course you are going
to have ischemic injury.
Dr. Qayumi. I would personally believe that first the
ischemic injury occurs, then as a result of that, the blood
vessel would be plugged as you described. But that is my
personal opinion.
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